Patients’ medical cannabis use does not measurably impact their reaction time or information processing speed, researchers concluded.
The post Analysis: Few Changes in Patients’ Cognitive Performance Following Their Use of Medical Cannabis Products appeared first on NORML.
Investigators reported no significant differences in sperm concentration, volume, or motility in cannabis consumers versus non-users.
The post Study: Cannabis Use Has No Significant Adverse Impact on Sperm Motility appeared first on NORML.
Forty-nine percent of patients experienced a greater than 25 percent reduction in seizure frequency following CBD treatment.
The post Study: FDA-Approved CBD Formulation Significantly Reduces Seizure Frequency in Young People With Refractory Epilepsy appeared first on NORML.
The company’s product offering will be distributed by licensed Australian manufacturer and wholesaler Canngea.
The former owner of the Washington, D.C.-based cannabis retailer admitted to not paying federal income and employment taxes for five tax years.
Terry Cole, Trump’s nominee to lead the Drug Enforcement Administration, said he would provide “careful consideration” to the rescheduling matter.
Harvest Grows will operate the company’s branded retail facility in Lorain under a licensing agreement.
Under the management services agreement, Glass House will manage LEEF’s dispensary in Palm Desert, Calif.
The Senate Law and Justice Committee rejected a partisan adult-use legalization bill despite its members offering support for policy reform.
Staffing agency Vangst released its 2025 Cannabis Jobs Report, providing a state-by-state analysis of employment, retail performance and workforce trends.